Beyond Air, Inc. - רווח החברה לפני מסים, ריבית ופחת XAIR

Beyond Air, Inc. (XAIR) is implementing AI modules and accounting automation to optimize its back office. The company is developing the LungFit portable system, which replaces heavy cylinders for lung treatment. Current operating profit in cash confirms liquidity dynamics, where the indicator value is 0.00. Stringent safety standards and gas delivery patents create high barriers to entry for new players in this niche.

This indicator measures net cash flow from operating activities before depreciation, allowing for an assessment of the business's actual ability to generate cash excluding accounting write-offs. An analysis of the organization's total EBITDA confirms the efficiency of the LungFit tankless technology, which reduces clinic operating costs, thereby enhancing the long-term investment attractiveness of Beyond Air, Inc. (XAIR) through margin scalability.